Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...

U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication DemandAustin, May 06, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ibuprofen API Market size ...

Pharmaceutical Executive: What elements is the conversation about bringing pharma manufacturing home missing? Charlie Lyon: ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Since the start of the decade, Eli Lilly has committed to spend more than $50 billion to bolster its United States ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

Ankleshwar, India – July 22, 2024 – RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...